Thu, April 28, 2022

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $22 on, Apr 28th, 2022

Douglas Miehm of RBC Capital, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $27 to $22 on, Apr 28th, 2022.

Douglas has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $22 on, Tuesday, March 8th, 2022